IP Verse

Parenteral Pharmaceutical Formulation In Suspension, Having Sustained Release, In Low And Ultralow Dosage, In Hormonal Therapy In The Climacteric Syndrome - EP2520301

PATENT ANALYSIS

Patent Details

Grant Date
Mar 3, 2021
Company
TECHSPHERE, S.A. DE CV.
Oppositions

BESINS HEALTHCARE MONACO S.A.M

More patents of Techsphere, S.A. De Cv.

EP2520301

Want to monitor this patent?

Feel free to send us a message here and we will get back to you